TruLite Health Combats Clinical Bias

TruLite Health, the leader in health equity solutions, recently entered the commercial market with the Truity™ platform which uniquely focuses on clinical bias and provides multi-level interventions at the point of care within an integrated workflow solution. Significant early interest accelerated the need to build out the sales, support, and services staff to meet the growing demand. 

The Truity platform is powered by the world’s largest curated health equity knowledge base. Seamless within the EMR workflow, the system matches a patient’s health record and associated social data sets with the Truity knowledge base to provide personalized information and recommendations for clinicians and care teams to consider for diverse patients. The opportunity to provide equitable care at the point of care is a missing element in most organization’s health equity strategies. 

TruLite Health’s Truity Platform addresses healthcare bias by providing care teams with clinically based, actionable recommendations for diverse populations at the time of care (most often during appointment and as part of the care plan). Backed by more than 4,000 peer-reviewed articles, Truity provides clinicians with detailed insights into a patient’s race-specific risk factors, most of which are not widely known, based upon their medical profile and social data sets. For instance, lung function testing for Asian Americans and Black Americans uses unsubstantiated race correcting calculations for lung function compared to White Americans. This negatively impacts patient outcomes because diagnosing lung conditions and offering early intervention helps manage and slow the progression of the disease. And in pain management treatment, Black American patients are often denied adequate pain medication and are 19% less likely to be prescribed opioids and 22% less likely prescribed non-opioid pain options compared to White Americans.

“Systemic clinical bias must be addressed if we are to provide equitable care and improve outcomes, quality, and cost,” says Alan Roga, M.D., CEO and co-founder. “We are excited by the positive industry-wide reception for our solution and to partner with leading healthcare organizations in addressing systemic clinical bias as a necessary complement to existing Social Determinants of Health initiatives.”

Did You Know: TruLite Health recently closed a $7 million Series A financing round to fund the commercial growth of the organization. The financing was led by Osage Venture Partners with participation by Ensemble Innovation Ventures, Xcellerant Ventures and several existing seed investors.